IL1B and rheumatoid arthritis: Several FDA approved drugs including Rilonacept (IL-1 blocker), Anakinra (IL-1R antagonist) and Canakinumab (IL-1β neutralizing antibody) have been used against rheumatoid arthritis (Arnold et al., 2022).